Artwork

Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

1.24 - Next Steps for Psychedelic-Assisted Therapies in Australia

18:19
 
Share
 

Manage episode 358190075 series 2896878
Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this podcast, we discuss what the next steps are, following the TGA's decision to change the classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists.


Support the podcast


In this episode:

  • The mission of Mind Medicine in light of the rescheduling of psilocybin and MDMA for medical use in Australia effective July 1st, 2023.

  • The podcast will shift focus towards a more in-depth analysis of newly published research articles on psychedelics, as well as previous research

  • Mind Medicine Australia is a non-profit organization dedicated to increasing medical access and awareness of psychedelic-assisted therapies.

  • Psychedelics are chemical compounds that temporarily alter brain function resulting in an "altered state of consciousness."

  • Mind Medicine Australia aims to provide better treatment options for patients suffering from mental illness, with a focus on developing clinical implementation frameworks and therapist training protocols.

  • Starting July 1, 2023, authorized prescribers will be able to prescribe psilocybin and MDMA for patients with treatment-resistant depression and post-traumatic stress disorder.

  • Mind Medicine Australia is arranging for these medicines to be supplied through licensed pharmacists holding Schedule 8 permits.

  • Only specialized psychiatrists who meet certain qualifications will be able to prescribe psilocybin and MDMA.

  • Australia is the first nation in the world to reschedule these medicines for medical purposes.

  • Mind Medicine Australia has trained 240 medical professionals through its Certificate in Psychedelic-Assisted Therapies (CPAT) since 2021, and will shortly be launching dates for 2023 intakes.

Certificate in Psychedelic Assisted Therapies


Patient Support Fund (Donate)

Support this show http://supporter.acast.com/mind-medicine-australia.

Become a member at https://plus.acast.com/s/mind-medicine-australia.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

45 episodes

Artwork
iconShare
 
Manage episode 358190075 series 2896878
Content provided by Deborah Roberts. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Deborah Roberts or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

In this podcast, we discuss what the next steps are, following the TGA's decision to change the classification of psilocybin and MDMA to enable prescribing by authorised psychiatrists.


Support the podcast


In this episode:

  • The mission of Mind Medicine in light of the rescheduling of psilocybin and MDMA for medical use in Australia effective July 1st, 2023.

  • The podcast will shift focus towards a more in-depth analysis of newly published research articles on psychedelics, as well as previous research

  • Mind Medicine Australia is a non-profit organization dedicated to increasing medical access and awareness of psychedelic-assisted therapies.

  • Psychedelics are chemical compounds that temporarily alter brain function resulting in an "altered state of consciousness."

  • Mind Medicine Australia aims to provide better treatment options for patients suffering from mental illness, with a focus on developing clinical implementation frameworks and therapist training protocols.

  • Starting July 1, 2023, authorized prescribers will be able to prescribe psilocybin and MDMA for patients with treatment-resistant depression and post-traumatic stress disorder.

  • Mind Medicine Australia is arranging for these medicines to be supplied through licensed pharmacists holding Schedule 8 permits.

  • Only specialized psychiatrists who meet certain qualifications will be able to prescribe psilocybin and MDMA.

  • Australia is the first nation in the world to reschedule these medicines for medical purposes.

  • Mind Medicine Australia has trained 240 medical professionals through its Certificate in Psychedelic-Assisted Therapies (CPAT) since 2021, and will shortly be launching dates for 2023 intakes.

Certificate in Psychedelic Assisted Therapies


Patient Support Fund (Donate)

Support this show http://supporter.acast.com/mind-medicine-australia.

Become a member at https://plus.acast.com/s/mind-medicine-australia.



Hosted on Acast. See acast.com/privacy for more information.

  continue reading

45 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide